Watch for Autoimmune-Like Effects From Cancer Immunotherapy

October 2018

More patients using cancer immunotherapy will lead to questions about adverse effects with "immune checkpoint inhibitors."

Cancer immunotherapy works by teaching the patient's immune system to find and kill cancer cells. It's different from chemotherapy, which directly targets dividing cells...malignant or healthy.

Common immunotherapies include immune checkpoint inhibitors, such as pembrolizumab (Keytruda) or durvalumab (Imfinzi). They block signals that cancer cells use to disguise themselves from the immune system.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Sort Out Influenza Vaccine Options for 2018-19
Cardiology Address Depression in Post-MI Patients
Pregnancy Use FDA's Updated System to Decipher Med Safety in Pregnancy
Dermatology Help Get to the Bottom of Diaper Rash
Hematology & Oncology Watch for Autoimmune-Like Effects From Cancer Immunotherapy
Pharmacogenetics Don't Recommend Pharmacogenetic Testing for Most Patients
Endometriosis Consider Orilissa for Some Women With Endometriosis
Natural Medicines Focus on Safety if Patients Use Essential Oils
Generics Prepare for Generic Tadalafil and Vardenafil
HIV & AIDS Expect Integrase Inhibitors to Gain an Edge in Treating HIV
Epinephrine Be Ready for Questions About EpiPen Shortages and Generics
Antipsychotics Compare Aristada Initio and Perseris to Other Injectable Antipsychotics
Medicare Be Ready for Questions About 2019 Medicare Part D Changes

Watch for Autoimmune-Like Effects From Cancer Immunotherapy

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents